CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017	[1]
Current assets:
Cash and cash equivalents	$ 48,615	$ 73,336
Short-term marketable securities	6,865	55,739
Related party receivables from collaborative arrangements	65,136	70,540
Prepaid expenses and other current assets	513	754
Total current assets	121,129	200,369
Property and equipment, net	173	209
Capitalized fees paid to a related party, net	156,354	166,722
Other assets	37	37
Total assets	277,693	367,337
Current liabilities:
Accounts payable	109	601
Accrued personnel-related expenses	1,550	1,721
Accrued interest payable	1,775	5,920
Other accrued liabilities	865	1,500
Current portion of long-term debt	0	25,000
Total current liabilities	4,299	34,742
Long-term debt, net of current portion, discount and issuance costs	381,002	574,362
Other long-term liabilities	668	940
Commitments and contingencies
Stockholders' deficit:
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding
Common stock: $0.01 par value, 200,000 shares authorized, 101,189 and 102,046 shares issued as of September 30, 2018 and December 31, 2017, respectively	1,011	1,019
Treasury stock: 150 shares as of September 30, 2018 and December 31, 2017	(3,263)	(3,263)
Additional paid-in capital	1,258,350	1,258,151
Accumulated other comprehensive loss	(3)	(18)
Accumulated deficit	(1,367,452)	(1,498,748)
Total Innoviva stockholders' deficit	(111,357)	(242,859)
Noncontrolling interest	3,081	152
Total stockholders' deficit	(108,276)	(242,707)
Total liabilities and stockholders' deficit	$ 277,693	$ 367,337

[1] Condensed consolidated balance sheet as of December 31, 2017 has been derived from audited consolidated financial statements.